Location History:
- Daejon, KR (1999)
- Daejeon, KR (1997 - 2010)
Company Filing History:
Years Active: 1997-2010
Title: The Innovative Journey of Jay Hyok Chang
Introduction
Jay Hyok Chang, an accomplished inventor from Daejeon, South Korea, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio comprising nine patents, Chang's innovations primarily focus on advanced compositions that address critical health issues. His expertise in chemistry and drug development has positioned him as a key player in the industry.
Latest Patents
Among his latest contributions to the field, Chang has developed a patented composition known as the Salt of naphthyridine carboxylic acid derivative. This innovative formulation includes 7-(3-Aminomethyl-4-methoxyiminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid methanesulfonate hydrate, which demonstrates efficacy in antibacterial therapy. Another patent includes the Salt of naphthyridine carboxylic acid derivative, highlighting processes for their preparation, pharmaceutical compositions incorporating these compounds, and their application in combating bacterial infections.
Career Highlights
Jay Hyok Chang has built an impressive career with notable tenures at prominent companies such as LG Chemical Ltd. and LG Life Sciences, Limited. His work at these organizations has been instrumental in the advancement of pharmaceutical research and development, allowing him to contribute significantly to innovative solutions in healthcare.
Collaborations
Throughout his career, Chang has collaborated with esteemed colleagues, including Hoon Moo Choi and Do Hyun Nam. These partnerships have fostered a dynamic environment for innovation and the sharing of ideas, enhancing the quality and impact of their collective work in the pharmaceutical sector.
Conclusion
In summary, Jay Hyok Chang is a distinguished inventor whose contributions have significantly advanced the field of antibacterial therapies. His extensive patent portfolio reflects a commitment to innovation and a dedication to improving public health through effective pharmaceutical solutions. As he continues to develop new technologies and partnerships, Chang's impact on the industry is likely to grow even further.